Document is current
Any future updates will be listed below
-
Authors
van Selm, Lena
White, Trenton M.
Picchio, Camila A.
Requena-Méndez, Ana
Busz, Machteld
Perez Gayo, Roberto
Pouille, Aline
Gelabert, Pedro Mateu
Lazarus, Jeffrey V.
-
Funding
Funding for this research was provided by:
European Union’s Justice Programme — Drugs Policy Initiatives (101045837, 101045837, 101045837, 101045837, 101045837, 101045837)
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 27 December 2023
First Online: 13 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: JVL reports research grants to his institution from AbbVie, Gilead Sciences and MSD, and speaker fees from AbbVie, Gilead Sciences, Intercept, Janssen, MSD, Novo Nordisk, and ViiV, and an advisory board fee from AbbVie and Novavax, all unrelated to this work. CAP participated in a podcast financed by Gilead Sciences, unrelated to this work.
